MedPage Today) — The FDA added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) over the risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD), the agency announced Friday.
After a review…
Read More
- General
-
Featured
-
Featured
-
Featured
-
- Business
-
Featured
-
Featured
-
Featured
-
- Entertainment
- Health & Medical
- Science & Nature
- Technology
-
Featured
-
Featured
-
Featured
-
- Documentary
-
Featured
-
Featured
-
Featured
-
- Crypto & Blockchain
Select Page
Recent Comments